Lilly & CO Eli is > 10% Shareholder of Elanco Animal Health Inc. Currently has a direct ownership of 0 shares of ELAN, which is worth approximately $0. The most recent transaction as insider was on Mar 11, 2019, when has been sold 293,290,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

LILLY & Co ELI Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 11 2019
SELL
Sale (or disposition) back to the issuer
-
293,290,000 Reduced 100.0%
0 Common Stock

Also insider at

RNA
Avidity Biosciences, Inc. Healthcare
ZYME
Zymeworks Inc. Healthcare
LPTX
LEAP THERAPEUTICS, INC. Healthcare
SGTX
Sigilon Therapeutics, Inc. Healthcare
CLCD
CoLucid Pharmaceuticals, Inc.
L&C

Lilly & CO Eli

> 10% Shareholder
Indianapolis, IN

Track Institutional and Insider Activities on ELAN

Follow Elanco Animal Health Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ELAN shares.

Notify only if

Insider Trading

Get notified when an Elanco Animal Health Inc insider buys or sells ELAN shares.

Notify only if

News

Receive news related to Elanco Animal Health Inc

Track Activities on ELAN